This is nothing new. Trials are designed with the endpoint first. What endpoints do you want, engineer the study backwards from there. I commented (elsewhere) as far back as June 2021 that the adult trials were 'crafty', deaths were covered up because they were classified as having 'dropped out of the trial' because they died before the…
This is nothing new. Trials are designed with the endpoint first. What endpoints do you want, engineer the study backwards from there. I commented (elsewhere) as far back as June 2021 that the adult trials were 'crafty', deaths were covered up because they were classified as having 'dropped out of the trial' because they died before the end of the 2 month monitoring period. These same issues that Dr. C bring up, I brought up in communication to FDA regarding the pediatric extension study, poorly, (but brilliantly), designed to meet their pre-designed endpoints. This is nothing new.
This is nothing new. Trials are designed with the endpoint first. What endpoints do you want, engineer the study backwards from there. I commented (elsewhere) as far back as June 2021 that the adult trials were 'crafty', deaths were covered up because they were classified as having 'dropped out of the trial' because they died before the end of the 2 month monitoring period. These same issues that Dr. C bring up, I brought up in communication to FDA regarding the pediatric extension study, poorly, (but brilliantly), designed to meet their pre-designed endpoints. This is nothing new.